Form 4: Moderna Director Abbas Hussain Reports Stock Transactions
SEC Form 4 Filing
Director Abbas Hussain reports the vesting and conversion of restricted stock units into Moderna common stock.
Summary
- On April 30, 2025, Moderna Director Abbas Hussain reported transactions involving restricted stock units (RSUs).
- 892 RSUs vested and were converted into 892 shares of common stock.
- Additionally, 16,233 RSUs were acquired, which will vest on the earlier of April 30, 2026, or Moderna's next Annual Meeting of Shareholders, subject to continued service.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment.
Future Outlook
The vesting schedule for the newly acquired RSUs extends to April 30, 2026, or the next Annual Meeting of Shareholders, indicating continued alignment of the director's interests with the company's performance.
Industry Context
Form 4 filings are standard practice for reporting insider transactions and provide transparency to investors regarding the actions of company directors and officers.
Stakeholder Impact
- The filing provides transparency to shareholders regarding insider transactions, which can influence investor confidence.
Key Dates
| Date | Description |
|---|---|
| 04/30/2025 | Date of transaction: vesting and conversion of 892 RSUs and acquisition of 16,233 RSUs. |
| 04/30/2026 | Vesting date for 16,233 RSUs, or earlier if Moderna's next Annual Meeting of Shareholders occurs before this date. |
| 05/01/2025 | Date of signature by Attorney-in-Fact. |
Keywords
Moderna, MRNA, Director, Abbas Hussain, Form 4, Stock, Restricted Stock Units, RSU, Vesting, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.